Could auto-antibodies be linked to severe Covid-19?
Drug Discovery World
JUNE 20, 2024
Researchers have revealed that auto-antibodies block interferon signalling, contributing to severe Covid-19 by impairing the patient’s immune response. Scientists have found that some people who suffered from Covid-19 had auto-antibodies targeting their own type 1 interferons, which are important immune signalling proteins.
Let's personalize your content